Parisa Amjadi

944 total citations
15 papers, 762 citations indexed

About

Parisa Amjadi is a scholar working on Immunology, Cancer Research and Oncology. According to data from OpenAlex, Parisa Amjadi has authored 15 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Parisa Amjadi's work include T-cell and B-cell Immunology (12 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). Parisa Amjadi is often cited by papers focused on T-cell and B-cell Immunology (12 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). Parisa Amjadi collaborates with scholars based in United Kingdom, Denmark and Iran. Parisa Amjadi's co-authors include Fionula M. Brennan, Patricia Green, Alan Kennedy, Adam P. Cribbs, Bernard Gregory, Marc Feldmann, Henry Penn, Jordan E. Read, Richard Williams and Brian M. J. Foxwell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Parisa Amjadi

14 papers receiving 750 citations

Peers

Countries citing papers authored by Parisa Amjadi

Since Specialization

Citations

This map shows the geographic impact of Parisa Amjadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parisa Amjadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parisa Amjadi more than expected).

Fields of papers citing papers by Parisa Amjadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parisa Amjadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parisa Amjadi. The network helps show where Parisa Amjadi may publish in the future.

Co-authorship network of co-authors of Parisa Amjadi

This figure shows the co-authorship network connecting the top 25 collaborators of Parisa Amjadi. A scholar is included among the top collaborators of Parisa Amjadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parisa Amjadi. Parisa Amjadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Total IgE levels in patients with hematologic malignancies 2025 ·World Allergy Organization Journal ·Parisa Amjadi, (unknown), Ehsan Zaboli, (unknown), Hossein Asgarian‐Omran, Akbar Hedayatizadeh‐Omran, (unknown), Reza Alizadeh‐Navaei	0
2	Human blood CD1c dendritic cells stimulate IL-12-independent IFN-γ responses and have a strikingly low inflammatory profile 2015 ·Journal of Leukocyte Biology ·Adel Benlahrech, Sai Duraisingham, (unknown), (unknown), (unknown), Parisa Amjadi, Tom Ford, Peter Kelleher, Steven Patterson	16
3	Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis 2015 ·Arthritis & Rheumatology ·Adam P. Cribbs, Alan Kennedy, Henry Penn, Parisa Amjadi, Patricia Green, Jordan E. Read, Fionula M. Brennan, Bernard Gregory, Richard Williams	120
4	Treg Cell Function in Rheumatoid Arthritis Is Compromised by CTLA‐4 Promoter Methylation Resulting in a Failure to Activate the Indoleamine 2,3‐Dioxygenase Pathway 2014 ·Arthritis & Rheumatology ·Adam P. Cribbs, Alan Kennedy, Henry Penn, Jordan E. Read, Parisa Amjadi, Patricia Green, (unknown), Szymon W. Manka, Fionula M. Brennan, Bernard Gregory, Richard Williams	114
5	A novel upstream enhancer of FOXP3, sensitive to methylation‐induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells 2014 ·European Journal of Immunology ·Alan Kennedy, Emily M. Schmidt, Adam P. Cribbs, Henry Penn, Parisa Amjadi, (unknown), Jordan E. Read, Patricia Green, Bernard Gregory, Fionula M. Brennan	47
6	Blockade of NKG2D ameliorates disease in mice with collagen‐induced arthritis: A potential pathogenic role in chronic inflammatory arthritis 2011 ·Arthritis & Rheumatism ·Anna Andersson, Percy F. Sumariwalla, Fiona E. McCann, Parisa Amjadi, Chiwen Chang, Kay McNamee, Ditte Tornehave, Claus Haase, Henrik Agersø, (unknown), David Ahern, Birgitte Ursø, John Trowsdale, Marc Feldmann, Fionula M. Brennan	44
7	Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells 2011 ·Proceedings of the National Academy of Sciences ·Paul A. Beavis, Bernard Gregory, Patricia Green, Adam P. Cribbs, Alan Kennedy, Parisa Amjadi, Andrew C. Palfreeman, Marc Feldmann, Fionula M. Brennan	48
8	Activation of p38 mitogen-activated protein kinase is critical step for acquisition of effector function in cytokine-activated T cells, but acts as a negative regulator in T cells activated through the T-cell receptor 2010 ·Immunology ·Ching Li, Paul A. Beavis, Andrew C. Palfreeman, Parisa Amjadi, Alan Kennedy, Fionula M. Brennan	20
9	Interleukin‐10 regulates TNF‐α−converting enzyme (TACE/ADAM‐17) involving a TIMP‐3 dependent and independent mechanism 2008 ·European Journal of Immunology ·Fionula M. Brennan, Patricia Green, Parisa Amjadi, Heidi Robertshaw, (unknown), Masao Takata	41
10	Resting CD4+effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell function 2008 ·Arthritis Research & Therapy ·Fionula M. Brennan, (unknown), (unknown), Ching Li, Parisa Amjadi, Patricia Green, Anna Andersson, Andrew C. Palfreeman, Philippa Hillyer, Andrew Foey, Jonathan T. Beech, Marc Feldmann	45
11	The Toll-Like Receptor Adaptor Proteins MyD88 and Mal/TIRAP Contribute to the Inflammatory and Destructive Processes in a Human Model of Rheumatoid Arthritis 2007 ·American Journal Of Pathology ·Sandra Sacre, Evangelos Andreakos, Serafim Kiriakidis, Parisa Amjadi, Anna M. Lundberg, Grey Giddins, Marc Feldmann, Fionula M. Brennan, Brian M. J. Foxwell	160
12	TCRζdimlymphocytes define populations of circulating effector cells that migrate to inflamed tissues 2007 ·Blood ·Zhuoli Zhang, Claire Gorman, (unknown), Claudia Monaco, Andrew Foey, (unknown), Parisa Amjadi, (unknown), C McClinton, Federica M. Marelli‐Berg, Pia Isomäki, Andrew B. Russell, Francesco Dazzi, Timothy J. Vyse, Fionula M. Brennan, Andrew P. Cope	34
13	Human BDCA-1-Positive Blood Dendritic Cells Differentiate into Phenotypically Distinct Immature and Mature Populations in the Absence of Exogenous Maturational Stimuli: Differentiation Failure in HIV Infection 2005 ·The Journal of Immunology ·Steven Patterson, Heather Donaghy, Parisa Amjadi, Brian Gazzard, Frances Gotch, Peter Kelleher	33
14	Sustained downregulation of the TCRζ chain defines a transition from antigen mode to inflammation mode during terminal T-cell differentiation 2005 ·Arthritis Research ·(unknown), (unknown), Parisa Amjadi, Andrew Foey, S. Owen, Francesco Dazzi, (unknown), Andrew P. Cope	2
15	Increased serum transforming growth factor-β1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration 2003 ·Clinical & Experimental Immunology ·Anfei Huang, Jill Gilmour, Nesrina Imami, Parisa Amjadi, D C Henderson, T G Allen-Mersh	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact